Anti-angiogenic drugs work by targeting specific pathways and molecules involved in angiogenesis. The most common targets include Vascular Endothelial Growth Factor (VEGF) and its receptors. By blocking these pathways, the drugs can effectively starve the tumor, limiting its ability to grow and spread.
